JPH11253564A - Sponge for radiotherapy - Google Patents

Sponge for radiotherapy

Info

Publication number
JPH11253564A
JPH11253564A JP5667298A JP5667298A JPH11253564A JP H11253564 A JPH11253564 A JP H11253564A JP 5667298 A JP5667298 A JP 5667298A JP 5667298 A JP5667298 A JP 5667298A JP H11253564 A JPH11253564 A JP H11253564A
Authority
JP
Japan
Prior art keywords
sponge
collagen
approx
gelatin
thickness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5667298A
Other languages
Japanese (ja)
Inventor
Takehide Asano
武秀 浅野
Toru Fukunaga
徹 福長
Hiroshi Ito
伊藤  博
Akiko Tanaka
晶子 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koken Co Ltd
Original Assignee
Koken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koken Co Ltd filed Critical Koken Co Ltd
Priority to JP5667298A priority Critical patent/JPH11253564A/en
Publication of JPH11253564A publication Critical patent/JPH11253564A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092Details
    • A61N2005/1094Shielding, protecting against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092Details
    • A61N2005/1096Elements inserted into the radiation path placed on the patient, e.g. bags, bolus, compensators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

PROBLEM TO BE SOLVED: To prevent a heavy corpuscular ray trouble from occurring by crosslinking between molecules of, collagen, or a mixture of collagen and gelatin is, and a sponge having an elastic force is formed. SOLUTION: For example, oxygen-soluble athero-collagen is prepared to be an acidic solution (approx. PH3) of a concentration of approx. 1%. The solution is poured into a plastic tray of four edges of approx. 10 cm, in a manner to become approx. 15 cm high, and neutralized in an ammonia saturated gas. Then, a freeze-drying is performed, and a collagen sponge with a thickness of approx. 15 mm, is obtained. The collagen sponge is dipped in an ethanol solution of approx. 1% for approx. 3 hours, and after being crosslinked, the collagen sponge is dried with air. Then, the collagen sponge is dipped in water, and is pinched between plastic plates under the water-contained state, and is compressed to a height of 5 mm, and freeze-dried as is, and a compression- molded sponge is obtained. The compressed sponge is placed in water and swollen, and returned to the original thickness which is approx. 15 mm. Thus, this sponge which is used to prevent a heavy corpuscular ray trouble from occurring, is obtained.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、放射線治療の際に
生じる重粒子線障害を防止するのに使用する放射線治療
用スポンジに関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a radiotherapy sponge used for preventing heavy ion beam damage caused during radiotherapy.

【0002】[0002]

【従来技術】従来の悪性腫瘍等の除去は、開腹手術によ
り腫瘍を直接摘出するというものであった。この方法は
患者の負担が大きく、また術後の快復も長期間かかる
上、再手術となった場合には、さらに大きな負担とな
る。そこで開腹せずに治療できることが望まれ、その方
法の一つとして放射線を照射し悪性腫瘍細胞を破壊する
ことが行われている。
2. Description of the Related Art Conventionally, removal of a malignant tumor or the like has involved removing the tumor directly by laparotomy. This method imposes a heavy burden on the patient, takes a long time to recover after the operation, and further increases the burden when reoperation is performed. Therefore, it is desired that the treatment can be performed without laparotomy. As one of the methods, irradiation with radiation to destroy malignant tumor cells has been performed.

【0003】放射線治療は悪性腫瘍部位に放射線を照射
して治療する方法で、この方法は患者の身体的機能を損
なうことがなく、目的部位のみを治療することができ、
しかも開腹の必要がないため、術中や術後の患者の負担
が軽くいだけでなく快復も早い方法である。放射線治療
に使用される放射線には、X線、ガンマー線、重粒子
線、速中性子線、陽子線等があり、いずれも皮膚を通過
し目的とする部位で放射線を作用させることを目的とし
ている。
[0003] Radiotherapy is a method of irradiating and treating a malignant tumor site. This method can treat only a target site without impairing the physical function of the patient.
Moreover, since there is no need for laparotomy, the burden on the patient during and after the operation is not only light, but also the recovery is quick. Radiation used in radiation therapy includes X-rays, gamma rays, heavy ion beams, fast neutron beams, and proton beams, all of which are intended to pass through the skin and act on the target site. .

【0004】放射線は透過性が高いために、目的とする
部位を通過しその裏の部位にまで影響を及ぼしたり、あ
るいは目的の部位までの組織にダメージを与えることが
問題となっている。しかし、それら治療の中でも粒子
線、例えば重粒子線の場合には非常に高速な荷電を持っ
た粒子を使うため、それら他の組織へのダメージは少な
いと言われているが、それでも臓器同士が密着している
場合には治療を行うことが困難となる。そこでこれら臓
器の間にスペーサーを入れ、臓器間を離すことが考えら
れるがこの放射線治療では開腹し縫合した皮膚では照射
を行うことが出来ず、その使用は大きく制限される。
[0004] Due to the high transmittance of radiation, there is a problem in that it passes through a target site and affects a site behind the target site or damages tissue up to the target site. However, among those treatments, it is said that particle beams, for example, heavy particle beams, use very fast charged particles, so that damage to other tissues is small, but organs still When they are in close contact, it is difficult to perform treatment. Therefore, it is conceivable to insert a spacer between these organs to separate the organs from each other. However, in this radiotherapy, irradiation cannot be performed on the laparotomy-stitched skin, and its use is greatly limited.

【0005】[0005]

【発明が解決しようとする課題】そこで、本発明者は、
上記の問題点を解決するために種々検討した結果、内視
鏡下に小さくしたスペーサーを腹腔内に入れ、それを所
定の臓器間に設置することで目的とする臓器にのみに照
射を行うことが可能であることを見出し、更に検討した
結果、スペーサーとしてコラーゲンもしくはコラーゲン
とゼラチンとの混合物を使用することによって、そのス
ペーサーは最終的には吸収され、そのスペーサーを取り
除くための再手術は不用となる等の利点を見出し本発明
を完成したもので、本発明の目的は、放射線治療の際に
生じる重粒子線障害を防止するのに使用するコラーゲン
もしくはコラーゲンとゼラチンとの混合物よりなる放射
線治療用スポンジを提供することである。
Therefore, the present inventor has proposed:
As a result of various investigations to solve the above problems, it was found that a small spacer was inserted into the abdominal cavity under an endoscope and placed between predetermined organs to irradiate only the target organ. As a result of further investigation, it was found that by using collagen or a mixture of collagen and gelatin as a spacer, the spacer was eventually absorbed, so that reoperation for removing the spacer was unnecessary. An object of the present invention is to provide a radiotherapy consisting of collagen or a mixture of collagen and gelatin used to prevent heavy ion beam damage caused during radiotherapy. Is to provide a sponge.

【0006】[0006]

【課題を解決する手段】本発明の要旨は、コラーゲン又
はコラーゲンとゼラチンの混合物に分子間架橋を導入し
て不溶化された放射線用治療用スポンジであって、該ス
ポンジに加えた荷重を解除した際に原状に戻る力を有す
ることを特徴とする放射線治療用スポンジである。すな
わち、本発明の放射線治療用スポンジはコラーゲンまた
はコラーゲンとゼラチンの混合物が分子間架橋されてお
り、これによって該スポンジは充分な弾性力を持ち、圧
縮した際に復元するだけの充分な弾性力を有する。
The gist of the present invention is to provide a radiation treatment sponge which is insolubilized by introducing an intermolecular crosslink into collagen or a mixture of collagen and gelatin, wherein the sponge is released from a load applied thereto. A sponge for radiation therapy, characterized in that it has a force to return to its original state. That is, the sponge for radiotherapy of the present invention has an intermolecular cross-linked collagen or a mixture of collagen and gelatin, whereby the sponge has a sufficient elastic force, and has a sufficient elastic force to restore when compressed. Have.

【0007】[0007]

【発明の実施の形態】次に本発明について詳細に述べ
る。本発明におけるコラーゲンとはいかなるものでもよ
く、例を挙げれば酸可溶性コラーゲン、中性塩可溶性コ
ラーゲン、酵素可溶化コラーゲン、アルカリ可溶化コラ
ーゲンおよびこれらのコラーゲンを化学修飾したサクシ
ニル化コラーゲン、アシル化コラーゲン、メチル化コラ
ーゲン等がある。またゼラチンとはこれらのコラーゲン
を熱変性した分子量約10万の親ゼラチン、あるはそれ
を加水分解して得られる分子量10万以下のものであ
る。
Next, the present invention will be described in detail. The collagen in the present invention may be any collagen, for example, acid-soluble collagen, neutral salt-soluble collagen, enzyme-solubilized collagen, alkali-solubilized collagen and succinylated collagen obtained by chemically modifying these collagens, acylated collagen, There are methylated collagen and the like. Gelatin is a parent gelatin having a molecular weight of about 100,000 obtained by thermally denaturing such collagen, or a gelatin having a molecular weight of 100,000 or less obtained by hydrolyzing it.

【0008】本発明のスポンジ作製におけるコラーゲン
濃度は0.5%以上10%以下、特に1%以上5%以下
の範囲であることが望ましい。コラーゲン濃度はスポン
ジの弾性力および分解速度に影響する。すなわち、濃度
が高すぎると圧縮することができず、また分解速度が遅
すぎるが、逆に濃度が低すぎると復元できなくなり、分
解速度も速すぎる。また、コラーゲンと同濃度のゼラチ
ンを混合することによりスポンジの弾性力、分解力を調
製することもできる。コラーゲン濃度にもよるが、ゼラ
チンの混合比はコラーゲンの1/10〜1/2が望まし
い。
[0008] The collagen concentration in the preparation of the sponge of the present invention is desirably in the range of 0.5% to 10%, particularly 1% to 5%. Collagen concentration affects the elasticity and degradation rate of the sponge. That is, if the concentration is too high, compression cannot be performed, and the decomposition rate is too slow. Conversely, if the concentration is too low, restoration cannot be performed, and the decomposition rate is too fast. Also, the elasticity and the decomposing ability of the sponge can be adjusted by mixing the same concentration of gelatin as collagen. Although depending on the collagen concentration, the mixing ratio of gelatin is preferably 1/10 to 1/2 of that of collagen.

【0009】調製したコラーゲン溶液あるいはコラーゲ
ンとゼラチンの混合溶液からスポンジを作製する。その
際、スポンジの厚みが少ないと放射線を照射する際にス
ポンジの留置した範囲からはずれてしまい、周囲の組織
を損傷する恐れがあるためある程度の厚みを与えること
が必要である。従ってスポンジの厚みは10mm以上で
あることが望ましい。スポンジを作製する手段は特に限
定されないが、例えば型に流し込んだ後、凍結乾燥して
スポンジを得ることができる。
A sponge is prepared from the prepared collagen solution or a mixed solution of collagen and gelatin. At that time, if the thickness of the sponge is small, the sponge is out of the indwelling area when irradiating radiation, and there is a possibility of damaging surrounding tissues. Therefore, it is necessary to provide a certain thickness. Therefore, it is desirable that the thickness of the sponge is 10 mm or more. The means for producing the sponge is not particularly limited. For example, the sponge can be poured into a mold and then freeze-dried to obtain a sponge.

【0010】得られたスポンジは水に入れても崩れない
ように架橋する。架橋方法は限定されないが、例えば紫
外線架橋、グルタルアルデヒド(GA)架橋、ヘキサメ
チレンジイソシアネート(HMDIC)架橋、ホルマリ
ン架橋、エポキシ架橋等が利用できる。本発明のスポン
ジはスペーサとして使用するため、また後で述べる様に
形状を小さくし腹腔内に導入し、その後腹腔内で広げる
ことが望まれるため、含水状態においても復元力を持つ
ことが必要となる。本発明のスポンジは厚さが10mm
以上で、その復元力は含水状態において、40g/cm
2の荷重を加えた場合にその厚みの減少が5mm以下
で、かつその荷重を除いた場合に元の厚みに復元する力
が望ましい。
The obtained sponge is crosslinked so that it does not collapse even when it is put in water. The crosslinking method is not limited, and for example, ultraviolet crosslinking, glutaraldehyde (GA) crosslinking, hexamethylene diisocyanate (HMDIC) crosslinking, formalin crosslinking, epoxy crosslinking and the like can be used. Since the sponge of the present invention is used as a spacer, and it is desired that the sponge is reduced in size and introduced into the abdominal cavity and then expanded in the abdominal cavity as described later, it is necessary to have a restoring force even in a water-containing state. Become. The sponge of the present invention has a thickness of 10 mm
As described above, the restoring force is 40 g / cm in a hydrated state.
Desirably, the thickness is reduced to 5 mm or less when a load of 2 is applied, and the force restores the original thickness when the load is removed.

【0011】本スポンジはそのまま留置する部位に入れ
ることも可能であるが、その場合は開腹する必要が生じ
る。そこでラパロスコープ下の手術により所定の部位に
スポンジを留置できることが望ましい。そのためにスポ
ンジを圧縮し、トラッカー等、腹腔に開けた小径の穴よ
り器具を通じて留置することが行われる。スポンジを体
内に導入するトラッカーの内径にあわせて円柱形に圧縮
成形し、凍結乾燥することによってトラッカー内を通す
ことが可能な形状にする。得られたスポンジをラパロス
コープ下の手術で体内に留置する場合には、トラッカー
内でスポンジを生理食塩水等で膨潤させておくことも可
能である。また留置した後スポンジが含水状態となり所
望の形状に復元し、目的部位でスペーサーとしての機能
を発現することが出来る。
Although the present sponge can be put into the place where it is to be kept, it is necessary to open the abdomen. Therefore, it is desirable that a sponge can be placed at a predetermined site by an operation under a laparoscope. For this purpose, the sponge is compressed and placed through a device such as a tracker through a small-diameter hole opened in the abdominal cavity. The sponge is compression-molded into a cylindrical shape according to the inner diameter of the tracker to be introduced into the body, and is freeze-dried to a shape that can be passed through the tracker. When the obtained sponge is to be kept in the body by an operation under a laparoscope, the sponge can be swollen with a physiological saline or the like in the tracker. In addition, after being placed, the sponge becomes hydrated and is restored to a desired shape, so that a function as a spacer can be exhibited at a target portion.

【0012】[0012]

【実施例】以下、実施例により本発明をさらに詳細に説
明するが、これらの例に限定されるものではない。 実施例1 酵素可溶化アテロコラーゲンを濃度1%の酸性溶液(p
H3)になるように調製した。この溶液を10cm四方
のプラスチックトレーに高さ15mmとなるように流し
込み、アンモニア飽和ガス中に静置して中和した後、凍
結乾燥により厚さ15mmのコラーゲンスポンジを得
た。このスポンジをHMDICのメタノール溶液(1
%)に3時間浸漬して架橋し、風乾した。これを水に浸
漬した含水状態でプラスチック板2枚で挟んで高さ5m
mになるように圧縮し、そのまま凍結乾燥して圧縮成形
したスポンジを得た。圧縮スポンジの厚みは5mmであ
った。この圧縮スポンジを水に入れたところ膨潤し、も
との厚み(15mm)に復元することを確認した。
EXAMPLES Hereinafter, the present invention will be described in more detail with reference to Examples, but it should not be construed that the invention is limited thereto. Example 1 A 1% concentration of an acidic solution (p
H3). This solution was poured into a 10 cm square plastic tray so as to have a height of 15 mm, neutralized by standing in an ammonia saturated gas, and then freeze-dried to obtain a collagen sponge having a thickness of 15 mm. This sponge was placed in a methanol solution of HMDIC (1
%) For 3 hours to crosslink and air dry. This is immersed in water and sandwiched between two plastic plates in a water-containing state, and the height is 5 m.
m, and then freeze-dried to obtain a compression-molded sponge. The thickness of the compression sponge was 5 mm. It was confirmed that when the compressed sponge was put in water, it swelled and was restored to its original thickness (15 mm).

【0013】実施例2 酵素可溶化アテロコラーゲンを濃度2%の酸性溶液(p
H3)になるように調製した。このうち1/5を60℃
で30分間加熱変性してゼラチン溶液とし、コラーゲ
ン:ゼラチン=4:1で混合してコラーゲン/ゼラチン
混合溶液を得た。この溶液を10cm四方のプラスチッ
クトレーに高さ15mmとなるように流し込み、アンモ
ニア飽和ガス中に静置して中和した後、凍結乾燥により
厚さ15mmのコラーゲン/ゼラチンスポンジを得た。
このスポンジをHMDICのメタノール溶液(1%)に
3時間浸漬して架橋し、風乾した。これを50mm×3
0mmの平面(高さ15mm)にカットし、水に浸漬し
て膨潤させた後に圧縮した状態で10mlのディスポシ
リンジ(テルモ製)の外筒に詰め、そのまま凍結乾燥し
て円柱形に圧縮成形したスポンジを得た。圧縮スポンジ
の厚みは5mmであった。この圧縮スポンジをシリンジ
外筒から出して水に入れたところ膨潤し、もとの厚み
(15mm)を有する平板形に復元することを確認し
た。
Example 2 An enzyme-solubilized atelocollagen was added to an acidic solution (p
H3). 1/5 of this is 60 ° C
For 30 minutes to form a gelatin solution, and mixed at a collagen: gelatin = 4: 1 ratio to obtain a collagen / gelatin mixed solution. This solution was poured into a 10 cm square plastic tray so as to have a height of 15 mm, and neutralized by standing in an ammonia-saturated gas, followed by freeze-drying to obtain a 15 mm thick collagen / gelatin sponge.
This sponge was immersed in a methanol solution of HMDIC (1%) for 3 hours to crosslink, and air-dried. This is 50mm × 3
It was cut into a flat surface of 0 mm (height: 15 mm), immersed in water, swollen, packed in a 10 ml disposable syringe (made by Terumo) in a compressed state, freeze-dried as it was, and compression-molded into a cylindrical shape. Got a sponge. The thickness of the compression sponge was 5 mm. When this compressed sponge was taken out of the syringe outer cylinder and put in water, it was confirmed that the sponge swelled and was restored to a flat plate shape having the original thickness (15 mm).

【0014】実施例3 実施例2と同様にコラーゲン/ゼラチンスポンジを作製
した。このスポンジをHMDICのメタノール溶液(1
%)に3時間浸漬して架橋し、風乾した。これを水に浸
漬した含水状態でプラスチック板2枚で挟んで高さ5m
mになるように圧縮し、そのまま凍結乾燥して圧縮成形
したスポンジを得た。圧縮スポンジの厚みは5mmであ
った。この圧縮スポンジをウサギ腹腔に入れたところ、
腹腔内で膨潤してもとの厚み(15mm)に復元し、か
つ放射線照射時のスペーサーとして充分な弾性力を有す
ることを確認した。
Example 3 A collagen / gelatin sponge was prepared in the same manner as in Example 2. This sponge was placed in a methanol solution of HMDIC (1
%) For 3 hours to crosslink and air dry. This is immersed in water and sandwiched between two plastic plates in a water-containing state, and the height is 5 m.
m, and then freeze-dried to obtain a compression-molded sponge. The thickness of the compression sponge was 5 mm. When this compressed sponge was placed in the rabbit abdominal cavity,
It was confirmed that even when swelled in the abdominal cavity, it was restored to its original thickness (15 mm), and that it had sufficient elasticity as a spacer during irradiation.

【0015】実施例4 実施例2と同様にコラーゲン/ゼラチンスポンジを作製
した。このスポンジをHMDICのメタノール溶液(1
%)に3時間浸漬して架橋し、風乾した。これを水に浸
漬した含水状態にし、40g/cm2で荷重をかけたと
ころ、厚みの減少は3mmであり、かつ荷重を除くと元
の厚みまで復元した。
Example 4 A collagen / gelatin sponge was prepared in the same manner as in Example 2. This sponge was placed in a methanol solution of HMDIC (1
%) For 3 hours to crosslink and air dry. This was immersed in water to obtain a water-containing state, and when a load was applied at 40 g / cm 2 , the reduction in thickness was 3 mm, and when the load was removed, the original thickness was restored.

【0016】実施例5 実施例2と同様にコラーゲン/ゼラチンスポンジを作製
した。このときコラーゲンとゼラチンの混合比はコラー
ゲン:ゼラチン=2:1とした。このスポンジに重粒子
線を照射してみたところ、乾燥状態、含水状態のいずれ
においても分解されることなく照射前の形状を保ってお
り、放射線照射時のスペーサーとして充分な強度を有す
ることを確認した。
Example 5 A collagen / gelatin sponge was prepared in the same manner as in Example 2. At this time, the mixing ratio of collagen and gelatin was set to collagen: gelatin = 2: 1. When this sponge was irradiated with a heavy particle beam, it was confirmed that the sponge maintained its shape before irradiation without being decomposed in both the dry state and the water-containing state, and had sufficient strength as a spacer during irradiation. did.

【0017】[0017]

【発明の効果】以上述べたように、本発明は放射線治療
の際に臓器間に留置して目的部位以外の個所における放
射線障害を防止する放射線治療用スポンジあって、該ス
ポンジは復元性を有するのでトラッカー等によって腹腔
内に導入することができるので開腹手術を行うことなく
放射線治療を行うことができ、更に該スポンジは分子間
架橋を有するコラーゲンもしくはコラーゲンとゼラチン
との混合物で構成されているので、腹腔内に導入当初は
水には不溶性であるが、時間の経過にしたがって体内に
吸収される等の効果を奏する。
As described above, the present invention relates to a radiotherapy sponge which is placed between organs during radiotherapy to prevent radiation damage at locations other than the target site, and the sponge has a restoring property. Since it can be introduced into the abdominal cavity by a tracker or the like, radiation therapy can be performed without performing laparotomy, and the sponge is made of collagen having an intermolecular cross-link or a mixture of collagen and gelatin. Although it is insoluble in water when introduced into the abdominal cavity, it has effects such as being absorbed into the body over time.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 田中 晶子 東京都新宿区大久保2−2−6 第3松田 ビル10階 株式会社高研研究所内 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Akiko Tanaka 2-2-6 Okubo, Shinjuku-ku, Tokyo 10th floor of the 3rd Matsuda Building Inside the Koken Research Institute Co., Ltd.

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 コラーゲン又はコラーゲンとゼラチンの
混合物に分子間架橋を導入して不溶化された放射線用治
療用スポンジであって、該スポンジに加えた荷重を解除
した際に原状に戻る力を有することを特徴とする放射線
治療用スポンジ。
1. A radiotherapy sponge insolubilized by introducing an intermolecular crosslink into collagen or a mixture of collagen and gelatin, and having a force to return to its original state when the load applied to the sponge is released. A sponge for radiation therapy, characterized by the following.
【請求項2】 含水状態において厚さが10mm以上
で、40g/cm2の荷重を加えた場合に最大でその厚
みが5mm減少し、かつその荷重を除いた場合に元の厚
みに復元する力を有することを特徴とする請求項第1項
記載の放射線治療用スポンジ。
2. A force that reduces the thickness by a maximum of 5 mm when a load of 40 g / cm 2 is applied at a thickness of 10 mm or more in a hydrated state and restores the original thickness when the load is removed. The sponge for radiotherapy according to claim 1, characterized by having:
【請求項3】 コラーゲン又はコラーゲンとゼラチンの
混合物を中和後、分子間架橋を導入したことを特徴とし
た請求項第1項記載の放射線治療用スポンジ。
3. The sponge for radiotherapy according to claim 1, wherein an intermolecular cross-link is introduced after neutralizing collagen or a mixture of collagen and gelatin.
【請求項4】 分子間架橋導入後圧縮し、その体積を減
じた後に乾燥したことを特徴とした、請求項第1項記載
の放射線治療用スポンジ。
4. The sponge for radiotherapy according to claim 1, wherein the sponge is compressed after the introduction of intermolecular crosslinks, reduced in volume, and then dried.
【請求項5】 コラーゲンとしてアテロコラーゲンを5
0%以上含有することを特徴とした請求項第1項記載の
放射線治療用スポンジ。
5. Atelocollagen is used as collagen.
The sponge for radiotherapy according to claim 1, characterized in that it contains 0% or more.
【請求項6】 乾燥する際に凍結乾燥を行うことを特徴
とした請求項第1項記載の放射線治療用スポンジ。
6. The sponge for radiation therapy according to claim 1, wherein freeze-drying is performed when drying.
JP5667298A 1998-03-09 1998-03-09 Sponge for radiotherapy Pending JPH11253564A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5667298A JPH11253564A (en) 1998-03-09 1998-03-09 Sponge for radiotherapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5667298A JPH11253564A (en) 1998-03-09 1998-03-09 Sponge for radiotherapy

Publications (1)

Publication Number Publication Date
JPH11253564A true JPH11253564A (en) 1999-09-21

Family

ID=13033923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5667298A Pending JPH11253564A (en) 1998-03-09 1998-03-09 Sponge for radiotherapy

Country Status (1)

Country Link
JP (1) JPH11253564A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011055670A1 (en) 2009-11-05 2011-05-12 国立大学法人神戸大学 Spacer for ionized radiation therapy
WO2015099089A1 (en) 2013-12-27 2015-07-02 国立大学法人 群馬大学 Implantable spacer

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011055670A1 (en) 2009-11-05 2011-05-12 国立大学法人神戸大学 Spacer for ionized radiation therapy
JP5432281B2 (en) * 2009-11-05 2014-03-05 国立大学法人神戸大学 Ionizing radiation treatment spacer and a sheet including a fiber assembly for producing the spacer
KR20180012346A (en) 2009-11-05 2018-02-05 고쿠리츠다이가쿠호진 고베다이가쿠 Spacer for ionized radiation therapy
US10525281B2 (en) 2009-11-05 2020-01-07 National University Corporation Kobe University Spacer for ionized radiation therapy
WO2015099089A1 (en) 2013-12-27 2015-07-02 国立大学法人 群馬大学 Implantable spacer
US10179248B2 (en) 2013-12-27 2019-01-15 National University Corporation Gunma University Implantable spacer

Similar Documents

Publication Publication Date Title
US10390946B2 (en) Method for the preparation of biological tissue for dry use in an implant
CN103394116B (en) Hydrogel dressing capable of promoting wound healing and preparation method thereof
Stevens et al. In vivo biocompatibility of gelatin-based hydrogels and interpenetrating networks
CN102068714A (en) Collagen sponge and preparation method thereof
JP4459543B2 (en) Sustained release hydrogel formulation
CA2324958A1 (en) Pericardial tissue implants and methods of making them
US5800542A (en) Sterilization by gamma irradiation
EP2796100B1 (en) Gelling system for the removal of kidney stone fragments
JP2000237294A (en) Medical material containing hyaluronic acid gel
RU2003130092A (en) NEW BIOPOLYMERS OBTAINED BY SOLID-PHASE IRRADIATION IN THE ATMOSPHERE OF UNSATURATED GASES
JP2013508033A (en) Fatty acid adhesion barrier that separates tissues
CN112007200B (en) Antibacterial repair-promoting hemostatic anti-adhesion membrane and preparation method thereof
AU2015397501B2 (en) Method for manufacturing collagen film using ultraviolet light, collagen film manufactured by using same, and biomaterial prepared using collagen film
US4825851A (en) Method for comminuting kidney stones
JPH11253564A (en) Sponge for radiotherapy
KR101564745B1 (en) Preparation methods of porous foam composed chitosan-gelatin-algin using ultrasonication and radiation
US3451394A (en) Radiating tanned and untanned collagen prosthesis with 5 to 25 megarads of ionizing radiation
UTTAYARAT et al. Processing and characterization of antibacterial hydrogel sheet dressings composed of poly (vinyl alcohol) and silk fibroin for wound healing application
CN113908332B (en) Metal peroxide composite injectable hydrogel and preparation method and application thereof
EP0347496B1 (en) Method for treating material for implantation and implant
CN110124096B (en) Lysozyme/hyaluronic acid composite gel and preparation method and application thereof
CN107998453B (en) Surface-modified acellular matrix and modification method thereof
JP2004339395A (en) Gelatinous heat resistant molded body manufacturing method, and gelatinous heat resistant molded body
JP2019172720A (en) Method for manufacturing water insoluble molding, and water insoluble molding
Stangel-Wójcikiewicz et al. Microwave-assisted synthesis and characterization of novel chitosan-based biomaterials for pelvic organ prolapse treatment.